B Wilson, PH Sitarambhai, MS Sajeev… - … Journal of Drug …, 2011 - arjournals.org The objective of present work was to formulate and evaluate sustained release matrix tablets of levofloxacin for treating microbial infections effectively. Levofloxacin is the active component of the racemate ofloxacin, and used for treating a variety of clinical conditions such as ... Cached
[PDF] from pjps.pkS Shah, K Shah, SU JAN, K Ahmad… - Pakistan journal of …, 2011 - pjps.pk ABSTRACT Being controlled release dosage forms, tablets allow an improved absorption and release profiles of Ofloxacin. The fact that drugs with fine particles size can be compressed well after wetting, so in our research studies Ofloxacin controlled release matrix tablets were ... Related articles - View as HTML - All 2 versions
[PDF] from academicjournals.orgM Akhlaq, GM Khan, A Wahab… - African Journal of …, 2011 - academicjournals.org The main aim of the study was to develop once-daily controlled release matrix tablet of the selected propionic acid derivative flubiprofen (100 mg) using ethyl cellulose ether derivative release controlling polymer. Preformulation factors, including solubility, powder flowability and ... View as HTML
U Mikac, J Kristl… - Expert opinion on drug …, 2011 - informahealthcare.com Modified-release matrix tablets have been used extensively by the pharmaceutical industry as one of the most successful oral drug-delivery systems. The dominant matrix excipients for most modified-release formulations are hydrophilic polymers, which hydrate when in contact ... Related articles - All 4 versions
[PDF] from pharmscidirect.comMM Rahman, M Sayeed Hasan2, A Alam… - Int J …, 2011 - pharmscidirect.com 1Department of Pharmacy, Bangladesh University, Mohammadpur, Dhaka-1207, Bangladesh 2Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh 3Department of Pharmacy, Southeast University, Banani, ... Related articles - View as HTML - All 3 versions